Trio-Tech (TRT) director exercises 20,000 options at $5.27 - Form 4
Trio-Tech International (TRT) reported an insider transaction.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Trio-Tech International (TRT) reported an insider transaction. Director Jason T. Adelman exercised stock options (transaction code M) for 20,000 shares of common stock at $5.27 on 10/13/2025, increasing his direct holdings to 38,000 shares.
The options were exercisable from 02/19/2021 and expire on 02/18/2026. Following the exercise, the filing shows 0 derivative securities remaining.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Common Stock | 20,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 20,000 | $5.27 | $105K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did TRT report?
Was this an open-market purchase for TRT?
What were the key dates for the option grant?
Does the insider have remaining derivative securities after this action?
What is the insider’s relationship to Trio-Tech (TRT)?
AI-generated analysis. How Rhea-AI works. Not financial advice.